Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

AC Immune (ACIU) Non Operating Income (2016 - 2026)

AC Immune has reported Non Operating Income over the past 11 years, most recently at -$16601.1 for Q1 2026.

  • Quarterly Non Operating Income fell 104.38% to -$16601.1 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $636557.0 through Mar 2026, up 113.24% year-over-year, with the annual reading at $1.0 million for FY2025, 39.92% down from the prior year.
  • Non Operating Income was -$16601.1 for Q1 2026 at AC Immune, down from $2.4 million in the prior quarter.
  • Over five years, Non Operating Income peaked at $2.5 million in Q1 2024 and troughed at -$2.2 million in Q2 2025.
  • The 5-year median for Non Operating Income is -$15159.3 (2022), against an average of -$130329.4.
  • Year-over-year, Non Operating Income tumbled 2510.89% in 2023 and then surged 3732.21% in 2024.
  • A 5-year view of Non Operating Income shows it stood at -$51901.1 in 2022, then crashed by 2510.89% to -$1.4 million in 2023, then rose by 14.33% to -$1.2 million in 2024, then soared by 310.48% to $2.4 million in 2025, then crashed by 100.68% to -$16601.1 in 2026.
  • Per Business Quant, the three most recent readings for ACIU's Non Operating Income are -$16601.1 (Q1 2026), $2.4 million (Q4 2025), and $385033.7 (Q3 2025).